66 related articles for article (PubMed ID: 7357557)
1. Effect of thymidine on the toxicity, antitumor activity, and metabolism of 1-beta-D-arabinofuranosylcytosine in rats bearing a chemically induced colon carcinoma.
Danhauser LL; Rustum YM
Cancer Res; 1980 Apr; 40(4):1274-80. PubMed ID: 7357557
[No Abstract] [Full Text] [Related]
2. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
Danhauser LL; Rustum YM
Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210.
Kinahan JJ; Kowal EP; Grindey GB
Cancer Res; 1981 Feb; 41(2):445-51. PubMed ID: 7448789
[No Abstract] [Full Text] [Related]
4. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
Grant S; Lehman C; Cadman E
Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
[No Abstract] [Full Text] [Related]
5. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
[TBL] [Abstract][Full Text] [Related]
6. Thymidine enhancement of 1-beta-d-arabinofuranosylcytosine activity for mouse EL4 tumors.
Reiter H
Leuk Res; 1981; 5(3):259-63. PubMed ID: 7266020
[No Abstract] [Full Text] [Related]
7. Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.
Spiegelman S; Nayak R; Sawyer R; Stolfi R; Martin D
Cancer; 1980 Mar; 45(5 Suppl):1129-34. PubMed ID: 7357507
[No Abstract] [Full Text] [Related]
8. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor.
Smirnoff P; Liel Y; Gnainsky J; Shany S; Schwartz B
Oncol Res; 1999; 11(6):255-64. PubMed ID: 10691027
[TBL] [Abstract][Full Text] [Related]
11. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
Roberts D; Peck C
Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
[TBL] [Abstract][Full Text] [Related]
12. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
13. Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy.
Gandhi V; Estey E; Du M; Keating MJ; Plunkett W
Clin Cancer Res; 1997 Sep; 3(9):1539-45. PubMed ID: 9815841
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
[No Abstract] [Full Text] [Related]
15. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
[TBL] [Abstract][Full Text] [Related]
16. Radiopotentiating action of 1-beta-D-arabinofuranosylcytosine in a xenografted human colonic carcinoma.
Goldenberg DM
Proc Soc Exp Biol Med; 1970 Jun; 134(2):510-2. PubMed ID: 5419139
[No Abstract] [Full Text] [Related]
17. Schedule dependency of anticancer effect of 1-beta-D-arabinofuranosylcytosine on rat ascites hepatomas.
Abe I; Sato S; Watanabe M; Sato H
Sci Rep Res Inst Tohoku Univ Med; 1978 Sep; 25(1-2):20-3. PubMed ID: 741221
[No Abstract] [Full Text] [Related]
18. Cytotoxic effects of 1-beta-D-arabinofuranosyl-5-fluorocytosine and of 1-beta-D-arabinofuranosylcytosine in proliferating tissues in mice.
Lenaz L; Sternberg SS; Philips FS
Cancer Res; 1969 Oct; 29(10):1790-8. PubMed ID: 5823947
[No Abstract] [Full Text] [Related]
19. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
20. [Recent acquisitions in the metabolism, mechanism of action and toxicity of cytarabine].
Campio L
Minerva Med; 1971 Mar; 62(25):1319-32. PubMed ID: 5552474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
